Schedule 13G ownership disclosure

KALOBIOS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 48344T209

Event date: 2016-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
949,752
Percent of class
6.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000891092-16-016717
Form type
SC 13G
Filer
Dhar Kapil
CIK
CIK 1682320
Filed
Aug 16, 2016
Reporting period
Jun 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub